Skip to main content

Animations

MJFF Publications

3131 - 3140 of 9030 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • The philosophy of Constantine the Philosopher of Nicaea
    2021
    Summary Details
    RESTRICTED
    Title: The philosophy of Constantine the Philosopher of Nicaea
    Journal Name: Byzantinische Zeitschrift
    Publisher: Walter de Gruyter GmbH
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1515/bz-2021-9006
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Supplement (online only): Proceedings of the 14th Göttingen Meeting of the German Neuroscience Society 2021
    Journal Name: Neuroforum
    Publisher: Walter de Gruyter GmbH
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1515/nf-2021-2003
    Citation Count: 0
  • Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study
    2021
    Summary Details
    RESTRICTED
    Title: Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00368-9
    Citation Count: 66
  • Movement disorders research in 2021: cracking the paradigm
    2021
    Summary Details
    RESTRICTED
    Title: Movement disorders research in 2021: cracking the paradigm
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00413-0
    Citation Count: 19
  • Major advances in Parkinson's disease over the past two decades and future research directions
    2022
    Summary Details
    RESTRICTED
    Title: Major advances in Parkinson's disease over the past two decades and future research directions
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00448-3
    Citation Count: 17
  • Revisiting levodopa for advanced Parkinson's disease
    2022
    Summary Details
    RESTRICTED
    Title: Revisiting levodopa for advanced Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00435-5
    Citation Count: 2
  • Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
    2022
    Summary Details
    RESTRICTED
    Title: Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00400-8
    Citation Count: 186
  • Inconsistency and incongruence: the two diagnostic pillars of functional movement disorder
    2022
    Summary Details
    RESTRICTED
    Title: Inconsistency and incongruence: the two diagnostic pillars of functional movement disorder
    Journal Name: The Lancet
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s0140-6736(22)01184-9
    Citation Count: 11
  • Optimizing the reaction conditions for the GMP production of [18F]ACI-12589, a promising candidate in the development as a PET tracer targeting α-synuclein
    2022
    Summary Details
    RESTRICTED
    Title: Optimizing the reaction conditions for the GMP production of [18F]ACI-12589, a promising candidate in the development as a PET tracer targeting α-synuclein
    Journal Name: Nuclear Medicine and Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s0969-8051(22)00207-4
    Citation Count: 0
  • Mild and direct 18F radiofluorination of tetrazines through sulfonium salt precursors
    2022
    Summary Details
    RESTRICTED
    Title: Mild and direct 18F radiofluorination of tetrazines through sulfonium salt precursors
    Journal Name: Nuclear Medicine and Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s0969-8051(22)00209-8
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.